HBM Healthcare Investments
Research HBM Healthcare Investments (HBMN) on Bullrun: market cap CHF 1.63B, P/E 2.6, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHBMN
- ExchangeSW
- CountrySwitzerland
- SectorFinancial Services
- IndustryAsset Management
- CurrencyCHF
- Market capCHF 1.63B
- P/E2.6
- Dividend yield3.9%
- Financial periodQ2 2026
- RevenueCHF 238.97M
- Net incomeCHF 238.32M
- Free cash flow-CHF 1.31M
Valuation Snapshot
latest market cap is CHF 1.63B; P/E is 2.6; dividend yield is 3.9%.
Peer valuation comparison
Latest P/E is 2.57x versus a Financial Services sector median of 13.84x (81.5% below).
Latest dividend yield is 3.85% versus a Financial Services sector median of 3.86%.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-10 | CHF 1.63B | 2.6 | 3.6% | 9 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 9 CHF, yield 3.9%.
About HBM Healthcare Investments
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is HBM Healthcare Investments's market cap?
HBM Healthcare Investments's market capitalization is CHF 1.63B.
What is HBM Healthcare Investments's P/E ratio?
HBM Healthcare Investments's price-to-earnings (P/E) ratio is 2.6.
Does HBM Healthcare Investments pay a dividend?
HBM Healthcare Investments has a dividend yield of 3.9%.
What does HBM Healthcare Investments do?
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds.